Birch Allergy Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | ALK-Abelló A/S, Allergy Therapeutics Plc., Regeneron Pharmaceuticals Inc., Desentum

DelveInsight's "Birch Allergy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Birch Allergy, historical and forecasted epidemiology as well as the Birch Allergy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To know in detail about the Birch Allergy market outlook, drug uptake, treatment scenario and epidemiology trends, click here; Birch Allergy Market Forecast- https://www.delveinsight.com/sample-request/birch-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Some of the key facts of the Birch Allergy Market Report
• In February 2025, Regeneron Pharmaceuticals announced a study is researching 2 experimental drugs, REGN5713 and REGN5715, which are called REGN5713-5715 when mixed together (called "study drug") to reduce eye allergy signs and symptoms due to birch tree pollen allergy.
• The Birch Allergy market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• The pooled prevalence figures, according to the French business DJO Global, show that 35% of people over 65 and 23% of adults aged 18 to 65 in France suffer with Birch Allergy
• According to a study by "Forkel et al. (2020), the prevalence of sensitization to one or more aeroallergens was estimated to be 33.6% of the general population in Germany based on the "German Health Interview and Examination Survey for Adults" (DEGS1) from 2008 to 2011
• The most prevalent seasonal allergy is birch pollen allergy. Between 8 and 16% of people are allergic-sensitized. There are seven different forms of birch pollen allergens, but Bet v 1 specific IgE is the most common one
• The leading Birch Allergy Companies such as ALK-Abelló A/S, Allergy Therapeutics Plc., Regeneron Pharmaceuticals Inc., Desentum., HAL Allergy Group., Roxall Medizin GmbH., Worg Pharmaceuticals AG., S-TARget therapeutics GmbH., Adamis Pharmaceuticals Crp., and others
• Promising Birch Allergy Therapies such as REGN5713-5714-571, SQ tree SLIT-tablet, ILT-101, sublingual immunotherapy, AllerT, and others

Stay ahead in the Birch Allergy Therapeutics Market with DelveInsight's Strategic Report @ Birch Allergy Market Outlook- https://www.delveinsight.com/sample-request/birch-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Birch Allergy Epidemiology Segmentation in the 7MM
• Total Prevalence of Birch Allergy
• Prevalent Cases of Birch Allergy by severity
• Gender-specific Prevalence of Birch Allergy
• Diagnosed Cases of Episodic and Chronic Birch Allergy

Download the report to understand which factors are driving Birch Allergy epidemiology trends @ Birch Allergy Prevalence- https://www.delveinsight.com/sample-request/birch-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Birch Allergy Marketed Drugs
• ITULAZAX: ALK-Abello
ITULAZAX is a sublingual immunotherapy tablet developed by ALK-Abello A/S for the treatment of adults with moderate-to-severe allergic rhinitis (AR) and/or conjunctivitis induced by pollen from the birch tree. It is designed to provide long-term relief from birch pollen allergy symptoms. The tablet is administered sublingually and is effective in reducing symptoms and improving the quality of life for patients with birch pollen allergy.

Birch Allergy Emerging Drugs
• REGN5713-5714-5715: Regeneron Pharmaceuticals
REGN5713-5714-5715 is a cocktail of three Bet v1 monoclonal antibodies developed by Regeneron Pharmaceuticals for the treatment of birch pollen allergy. The mechanism of action involves the inhibition of Bet v 1, a major birch pollen allergen, by binding to IgE receptors and preventing the activation of mast cells and basophils, thereby reducing the allergic response. Regeneron is currently conducting a Phase III study to further evaluate the efficacy and safety of REGN5713-5714-5715 in a larger population of patients with birch pollen allergy.

Birch Allergy Therapies and Companies
• REGN5713-5714-5715: Regeneron Pharmaceuticals
• SQ tree SLIT-tablet: ALK-Abelló A/S
• ILT-101: Assistance Publique
• sublingual immunotherapy: HAL Allergy
• AllerT: Anergis

Discover more about therapies set to grab major Birch Allergy market share @ Birch Allergy Treatment Market- https://www.delveinsight.com/sample-request/birch-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Birch Allergy Market Drivers
• Increasing prevalence of Birch Allergy
• Ongoing development of precision medicine
• Expansion of health care system

Birch Allergy Market Barriers
• Ineffectiveness/Failure of Treatment
• Slow uptake of immunotherapy

Learn more about the FDA-approved drugs for Birch Allergy @ Drugs for Birch Allergy Treatment- https://www.delveinsight.com/sample-request/birch-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Birch Allergy Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Key Birch Allergy Companies: ALK-Abelló A/S, Allergy Therapeutics Plc., Regeneron Pharmaceuticals Inc., Desentum., HAL Allergy Group., Roxall Medizin GmbH., Worg Pharmaceuticals AG., S-TARget therapeutics GmbH., Adamis Pharmaceuticals Crp., and others
• Key Birch Allergy Therapies: REGN5713-5714-571, SQ tree SLIT-tablet, ILT-101, sublingual immunotherapy, AllerT, and others
• Birch Allergy Therapeutic Assessment: Birch Allergy current marketed and Birch Allergy emerging therapies
• Birch Allergy Market Dynamics: Birch Allergy market drivers and Birch Allergy market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Birch Allergy Unmet Needs, KOL's views, Analyst's views, Birch Allergy Market Access and Reimbursement

To know more about Birch Allergy companies working in the treatment market, visit @ Birch Allergy Clinical Trials and Therapeutic Assessment- https://www.delveinsight.com/sample-request/birch-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Birch Allergy Market Report Introduction
2. Executive Summary for Birch Allergy
3. SWOT analysis of Birch Allergy
4. Birch Allergy Patient Share (%) Overview at a Glance
5. Birch Allergy Market Overview at a Glance
6. Birch Allergy Disease Background and Overview
7. Birch Allergy Epidemiology and Patient Population
8. Country-Specific Patient Population of Birch Allergy
9. Birch Allergy Current Treatment and Medical Practices
10. Birch Allergy Unmet Needs
11. Birch Allergy Emerging Therapies
12. Birch Allergy Market Outlook
13. Country-Wise Birch Allergy Market Analysis (2019-2032)
14. Birch Allergy Market Access and Reimbursement of Therapies
15. Birch Allergy Market Drivers
16. Birch Allergy Market Barriers
17. Birch Allergy Appendix
18. Birch Allergy Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

List of Top Selling Market Research Reports in 2025

Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cardiac Implantable Electronic Devices Market- https://www.delveinsight.com/report-store/implantable-cardiac-monitors-market
Sleep Tech Devices Market- https://www.delveinsight.com/report-store/sleep-tech-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Indwelling Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
NK Cell Therapy Market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive Airway Pressure Device Market- https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Surgical Energy Instruments Market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Urea Cycle Disorders Market- https://www.delveinsight.com/report-store/urea-cycle-disorders-market
Testicular Neoplasm Market- https://www.delveinsight.com/report-store/testicular-cancer-pipeline-insight
Healthcare Competitive Benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Bone Growth Stimulator Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Surgical Mask & Respirator Market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 919650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.